Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Target Engagement for Terazosin in Parkinson's Disease (TZPD2)

NCT07464028 is registered in ClinicalTrials.gov with Ergun Y. Uc as lead sponsor.

NCT NCT07464028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07464028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Target Engagement for Terazosin in Parkinson's Disease (TZPD2)
Lead sponsor
Ergun Y. Uc
Phase
Phase 2
Overall status
Suspended
Start date
July 1, 2028
Completion date
July 1, 2031
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease (pd)